Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,874 | 161,376 | 61,688 | 151,337 | 179,759 |
| Marketable Securities | 420,463 | 400,137 | 388,557 | 354,989 | 373,414 |
| Receivables | 20,397 | 21,537 | 16,646 | 12,670 | 16,689 |
| Inventories | 18,765 | 6,712 | 4,523 | 7,297 | 7,632 |
| Other current assets | 0 | 0 | 2,990 | 0 | 0 |
| TOTAL | $542,055 | $604,904 | $486,437 | $534,842 | $586,777 |
| Non-Current Assets | |||||
| PPE Net | 8,570 | 9,127 | 9,049 | 9,557 | 10,080 |
| Intangibles | 154,456 | 162,883 | 97,073 | 149,469 | 149,920 |
| Other Non-Current Assets | 31,348 | 31,317 | 80,026 | 32,347 | 32,717 |
| TOTAL | $194,374 | $203,327 | $186,148 | $191,373 | $192,717 |
| Total Assets | $736,429 | $808,231 | $672,585 | $726,215 | $779,494 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,915 | 16,727 | 17,290 | 14,010 | 11,848 |
| Accrued Expenses | 88,749 | 85,766 | 95,742 | 88,383 | 82,694 |
| Other current liabilities | 12,140 | 12,632 | 5,722 | 13,023 | 13,324 |
| TOTAL | $135,711 | $130,645 | $142,163 | $131,032 | $124,492 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10,244 | 10,975 | 11,976 | 11,383 | 12,503 |
| Other Non-Current Liabilities | 477,445 | 479,668 | 476,640 | 481,588 | 482,054 |
| TOTAL | $484,233 | $488,446 | $487,571 | $494,507 | $498,289 |
| Total Liabilities | $619,944 | $619,091 | $629,734 | $625,539 | $622,781 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,011 | 74,608 | 64,745 | 64,174 | 63,958 |
| Common Shares | 7 | 7 | 6 | 6 | 6 |
| Retained earnings | -1,186,184 | -1,100,554 | -1,014,223 | -948,400 | -878,744 |
| Other shareholders' equity | -3,855 | -2,176 | -2,907 | 303 | -1,082 |
| TOTAL | $116,485 | $189,140 | $42,851 | $100,676 | $156,713 |
| Total Liabilities And Equity | $736,429 | $808,231 | $672,585 | $726,215 | $779,494 |